Suppr超能文献

补充维生素D和先前接种口服脊髓灰质炎病毒疫苗可降低近期接种灭活脊髓灰质炎病毒疫苗的成年人出现新冠病毒病相关结果的几率。

Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine.

作者信息

Comunale Brittany A, Hsu Yea-Jen, Larson Robin J, Singh Aditi, Jackson-Ward Erin, Engineer Lilly D

机构信息

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

出版信息

Vaccines (Basel). 2024 Jan 24;12(2):121. doi: 10.3390/vaccines12020121.

Abstract

BACKGROUND

Structural and functional commonalities between poliovirus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that poliovirus inoculation may induce antibodies that mitigate the coronavirus disease (COVID-19). No known studies have evaluated COVID-19 risk factors in adults recently vaccinated against poliovirus.

STUDY OBJECTIVE

Among adults with no history of COVID-19 infection or vaccination, who recently received an inactivated poliovirus vaccine (IPV), we sought to determine which biological factors and social determinants of health (SDOH) may be associated with (1) testing positive for SARS-CoV-2, (2) experiencing COVID-19 symptoms, and (3) a longer duration of COVID-19 symptoms.

METHODS

The influence of biological factors and SDOH on SARS-CoV-2 infection and COVID-19 symptoms were evaluated among 282 adults recently inoculated with IPV. Participant-reported surveys were analyzed over 12 months post-enrollment. Bivariate and multivariate linear and logistic regression models identified associations between variables and COVID-19 outcomes.

RESULTS

Adjusting for COVID-19 vaccinations, variants, and other SDOH, secondary analyses revealed that underlying conditions, employment, vitamin D, education, and the oral poliovirus vaccination (OPV) were associated with COVID-19 outcomes. The odds of testing positive for SARS-CoV-2 and experiencing symptoms were significantly reduced among participants who took vitamin D (OR 0.12 and OR 0.09, respectively). Unemployed or part-time working participants were 72% less likely to test positive compared with full-time workers. No prior dose of OPV was one of the strongest predictors of SARS-CoV-2 infection (OR 4.36) and COVID-19 symptoms (OR 6.95).

CONCLUSIONS

Findings suggest that prophylactic measures and mucosal immunity may mitigate the risk and severity of COVID-19 outcomes. Larger-scale studies may inform future policies.

摘要

背景

脊髓灰质炎病毒与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)之间的结构和功能共性表明,接种脊髓灰质炎病毒可能诱导产生减轻冠状病毒病(COVID-19)的抗体。尚无已知研究评估近期接种脊髓灰质炎病毒疫苗的成年人中的COVID-19风险因素。

研究目的

在没有COVID-19感染或疫苗接种史、近期接种了灭活脊髓灰质炎病毒疫苗(IPV)的成年人中,我们试图确定哪些生物学因素和健康的社会决定因素(SDOH)可能与(1)SARS-CoV-2检测呈阳性、(2)出现COVID-19症状以及(3)COVID-19症状持续时间较长有关。

方法

在282名近期接种IPV的成年人中评估生物学因素和SDOH对SARS-CoV-2感染和COVID-19症状的影响。在入组后的12个月内对参与者报告的调查进行分析。二元和多变量线性及逻辑回归模型确定变量与COVID-19结局之间的关联。

结果

在对COVID-19疫苗接种、病毒变体和其他SDOH进行调整后,二次分析显示基础疾病、就业情况、维生素D、教育程度和口服脊髓灰质炎病毒疫苗(OPV)与COVID-19结局有关。服用维生素D的参与者中,SARS-CoV-2检测呈阳性和出现症状的几率显著降低(分别为OR 0.12和OR 0.09)。与全职工作者相比,失业或兼职工作的参与者检测呈阳性的可能性低72%。未接种过OPV是SARS-CoV-2感染(OR 4.36)和COVID-19症状(OR 6.95)的最强预测因素之一。

结论

研究结果表明,预防措施和黏膜免疫可能降低COVID-19结局的风险和严重程度。大规模研究可能为未来政策提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcc/10892023/78ab64e84e8c/vaccines-12-00121-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验